We are live on ! Find out more
PMD

Psychemedics Corporation

Delisted

PMD was delisted on the 12th of December, 2024.

34 hedge funds and large institutions have $10M invested in Psychemedics Corporation in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 3534 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

30% less capital invested

Capital invested by funds: $14.4M → $10M (-$4.39M)

75% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 16

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
16
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NFG
26
Next Financial Group
Texas
$13K +$14.1K +2,900 New
TRCT
27
Tower Research Capital (TRC)
New York
$6K +$5.8K +1,190 +1,488%
Bank of America
28
Bank of America
North Carolina
$1K -$127 -26 -11%
Invesco
29
Invesco
Georgia
-$130K -23,460 Closed
Bank of New York Mellon
30
Bank of New York Mellon
New York
-$61K -11,074 Closed
GI
31
GS Investments
Minnesota
-$49.5K -9,000 Closed
UBS Group
32
UBS Group
Switzerland
-$6.5K -1,335 -97%
APA
33
American Portfolios Advisors
New York
-$1.89K -340 Closed

PMD Hedge Fund Activity: Q3 2020 in Review

34 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2020, worth a combined $10M — down 30% from $14.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PMD and 3 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 4 added.

The largest buyer was Invenomic Capital Management, adding an estimated $112K. The largest seller was Kennedy Capital Management, cutting an estimated $1.16M.

  • 34 institutional investors held Psychemedics Corporation (PMD) as of Q3 2020, down from 35 in Q2 2020.
  • Funds reported $10M of Psychemedics Corporation stock for Q3 2020, down 30% quarter-over-quarter.
  • 3 funds opened new Psychemedics Corporation positions in Q3 2020 and 4 closed out, a net change of -1 holder.
  • The largest Psychemedics Corporation buyer in Q3 2020 was Invenomic Capital Management, an estimated $112K added.
  • The largest Psychemedics Corporation seller in Q3 2020 was Kennedy Capital Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q3 2020.